about
Safety and efficiency of emergency department assessment of chest discomfort.Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis.A simplified D-shaped model of the mitral annulus to facilitate CT-based sizing before transcatheter mitral valve implantation.Percutaneous closure of prosthetic paravalvular leaks: case series and review.Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.Prevention and management of transcatheter balloon-expandable aortic valve malposition.Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis.Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter Study.Clinical characteristics, angiographic findings, and one-year outcome of 101 consecutive stent thrombosis cases in British Columbia.Transcatheter Aortic and Mitral Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves: An 8-Year Single-Center Experience.Usefulness of early positive technetium-99m stannous pyrophosphate scan in predicting reperfusion after thrombolytic therapy for acute myocardial infarction.Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes.Transcatheter closure of paravalvular defects using a purpose-specific occluder.Multidetector CT predictors of prosthesis-patient mismatch in transcatheter aortic valve replacement.Do younger women fare worse? Sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years.The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial.Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter.Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement.Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience.Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves.5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction.Transapical transcatheter aortic valve-in-valve implantation: clinical and hemodynamic outcomes beyond 2 years.Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve.Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis.A Strategy of Underexpansion and Ad Hoc Post-Dilation of Balloon-Expandable Transcatheter Aortic Valves in Patients at Risk of Annular Injury: Favorable Mid-Term Outcomes.Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients.Kidney function and mortality among patients with left ventricular systolic dysfunction.Three-Dimensional Echocardiography Compared With Computed Tomography to Determine Mitral Annulus Size Before Transcatheter Mitral Valve Implantation.Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentation.First-in-Man Experience of a Novel Transcatheter Repair System for Treating Severe Tricuspid Regurgitation.Role of echocardiography in percutaneous aortic valve implantation.Transesophageal echocardiography to guide pulmonary vein mapping and ablation for atrial fibrillation.Images in cardiovascular medicine: prosthetic aortic valve and conduit dehiscence with large periconduit cavity, ascending aortic aneurysm and severe mitral regurgitation.Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis.Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients.Rapid pacing to facilitate transcatheter prosthetic heart valve implantation.Determinants of percutaneous coronary intervention vs coronary artery bypass grafting: an interprovincial comparison.Percutaneous aortic valve implantation retrograde from the femoral artery.Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus.
P50
Q34341669-47208F82-5BA7-4C97-8120-F6ED3F7F25D1Q34467379-75D95D60-A720-4DB8-B74D-F48A51653B0EQ35212911-132EC8FE-EC71-4C2A-98C6-A033E825C834Q36592332-83F7A47D-DED0-4B3B-AE9C-B5A47404836CQ38419933-AE5A737C-9674-43D3-B9C1-D68044E20D88Q38442496-EDD2233D-A47E-4514-AC27-CD9F6908779DQ39314014-1CA7ACD0-94E1-453B-82AE-9A4E0F63515FQ39478801-50CC3965-B9FD-437B-A86A-0F850C81115EQ39832913-714DD11F-9DE8-4019-8BFD-24E59C17EA2FQ39976819-9F40C3A7-4BAE-4C84-AEC6-15082A8F0C17Q41206395-C9495EEA-19A3-4116-A4E1-1105335A5135Q41433191-8513CB92-ED4B-4128-8DE1-BBD7FF03AD61Q42623253-27A90B4B-B4DD-4E7F-BAD9-AAE62F3DDEFAQ42962302-A2E9D7F0-15C4-4981-BE1D-711056C82A8AQ43499151-1B98DDEC-63AC-4180-AC26-0C52A2590B22Q43515307-04C5A274-5547-4C64-83A3-814C20472B68Q43695994-36B0803F-E0E9-49AA-AFD8-B3B3B5180241Q43812652-86F43008-926D-4E2F-8D2A-AC3E8F78059FQ44239256-9154042C-63FC-4588-AEDF-00766CCE888CQ44596208-0025F841-5AA8-47FA-B1E8-0C665792785BQ44819078-28E7EBB2-F0AD-4685-B603-F06BBC2BBCE8Q44821615-365A6D0F-5AF9-4788-AFCA-5F7E2C4A6AA5Q45932884-83825BFD-5ADB-40DA-BC6D-6EE2E1C7020FQ45940739-4321D09D-9E00-4B29-956E-045BDA65F10DQ45977921-5C0D0A8C-C0EB-4411-A369-722859F6D195Q46189190-9FE5A8B8-463A-4371-B4A0-C06B00577A1CQ46375591-E97055CF-FD71-4D19-BAB0-6A0FCAB013B6Q46807791-53C4107C-0AA4-48E1-B571-8D2F834A37C7Q47296172-64A27577-97DD-4B6F-9EF4-DCD544B46B20Q47380842-DC437C92-0C13-4888-A42F-5C081A09AAE0Q47617846-745184A9-A515-4A28-A8CB-69293370F312Q48005199-D28E21AB-7A06-4EB8-9004-2631D6BC9693Q48873101-D31BEF76-6AFD-43FE-8C12-F3152F8B234DQ50933033-4AC35C0B-A0A1-4D19-ABAC-713717D34D26Q50952403-B0D3EB9C-E570-4C82-8F5D-901CB08E6F9BQ51100574-3D9A7AB6-FC64-4060-A12F-407AA4E44175Q51170495-D72E347C-F5EE-46ED-8793-633737E763A7Q51216775-23893ACA-2B10-409A-B995-E2F5C61B2FC2Q51275862-D9C17C2B-F1DE-4A80-A2B4-AACF0D4F23AEQ51275866-E2EB9DC5-CE37-420A-A612-6D6E5C9D0B37
P50
description
medical researcher
@en
onderzoeker
@nl
հետազոտող
@hy
name
Christopher R. Thompson
@ast
Christopher R. Thompson
@en
Christopher R. Thompson
@es
Christopher R. Thompson
@sl
type
label
Christopher R. Thompson
@ast
Christopher R. Thompson
@en
Christopher R. Thompson
@es
Christopher R. Thompson
@sl
prefLabel
Christopher R. Thompson
@ast
Christopher R. Thompson
@en
Christopher R. Thompson
@es
Christopher R. Thompson
@sl
P1053
F-3967-2010
P106
P1153
35391691100
P21
P31
P3829
P496
0000-0001-9206-376X